Our Parkinson's Place: New biopharm company formed to advance potential Parkinson's therapy

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

Wednesday, May 11, 2016

New biopharm company formed to advance potential Parkinson's therapy

May 10, 2016

Melior Discovery Inc. said Tuesday it has completed the formation of its second therapeutic area-focused pharmaceutical company.

The company, Melior Pharmaceuticals II in Exton, Pa., will focus on developing a new therapy for Parkinson’s disease.

Melior DIscovery CEO Andrew Reaume

Melior Discovery Inc., also of Exton, has transferred all of its intellectual property related to MLR-1019, a therapeutic candidate for Parkinson’s disease, into the new company.

The spinoff of the asset and its associated intellectual property, according to company officials, provides several benefits to Melior Discovery and its investors by creating an entity with which new investors and partners can form business relationships that are “unencumbered” by the other assets and operational activities of Melior Discovery Inc.

Founded in 2005, Melior Discovery focuses on repositioning and finding new uses for older therapeutic products.

MLR-1019 was available in the former Soviet Union for psychiatric indications, but was withdrawn from the market when its manufacturer discontinued operations.

“We are very enthusiastic about the promise that MLR-1019 holds for benefiting Parkinson’s patients,” said Andrew Reaume, CEO of Melior Discovery. “The formation of Melior Pharmaceuticals II will expedite our activities toward initiating clinical development.”

Melior Discovery previously established Melior Pharmaceuticals I, to developing a new candidate for type 2 diabetes. The product, MLR-1023, is in midstage clinical testing.